Core Viewpoint - The company announced the election of Mr. Tan Jian as the employee director of the fifth board of directors, with the term starting from November 28, 2025, until the end of the board's term [2] Summary by Sections - Announcement Details - The company will hold an employee representative meeting on November 28, 2025, to elect Mr. Tan Jian as the employee director [2]

证券代码：603883 证券简称：老百姓 公告编号：2025-067 公司分别于 2025 年 10 月 28 日、2025 年 11 月 28 日召开第五届董事会第十 一次会议和 2025 年第一次临时股东大会，审议通过了《关于变更注册资本并修 订<公司章程>的议案》，公司不再设置监事会，董事会成员包含一名职工代表董 事。 公司于 2025 年 11 月 28 日召开职工代表大会，选举谭坚先生担任公司第五 届董事会职工董事，任期自 2025 年 11 月 28 日起至公司第五届董事会任期届满 之日止。 一、董事/高级管理人员离任情况 | 姓名 | 离任职务 | 离任时间 | 原定任期 | 离任原因 | 是否继续在上 市公司及其控 | 具体职务 | 是否存在 未履行完 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 到期日 | | 股子公司任职 | （如适用） | 毕的公开 | | | | | | | | | 承诺 | | 刘晓恩 | 董事 | 2025 年 11 | 2027 年 2 月 | 个人工作 | 否 | 不适用 | 否 | | ...

证券代码：603883 证券简称：老百姓 公告编号：2025-066 老百姓大药房连锁股份有限公司 2025年第一次临时股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一)股东大会召开的时间：2025 年 11 月 28 日 (二)股东大会召开的地点：湖南省长沙市开福区青竹湖路 808 号老百姓 15 楼会 议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 593 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 371,553,471 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | 48.9601 | | 份总数的比例（%） | | (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次会议采取现场投票和网络投票相结合的方式召开，老百姓大药房连锁股份有 限公司（以下简称"公司"）董事会召集本次会 ...

湖南启元律师事务所 关于老百姓大药房连锁股份有限公司 2025年第一次临时股东大会的 法律意见书 二零二五年十一月二十八日 湖南启元律师事务所（以下简称"本所"）接受老百姓大药房连锁股份有限 公司（以下简称"公司"）的委托，指派律师出席了公司 2025 年第一次临时股东 大会（以下简称"本次股东大会"），对本次股东大会的召集和召开程序、出席 会议人员及召集人的资格、表决程序和表决结果的合法有效性进行律师见证，并 发表本法律意见。 本所根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华 人民共和国证券法》（以下简称"《证券法》"）、《上市公司股东会规则》（以 下简称"《股东会规则》"）等我国现行法律、法规、规范性文件以及《老百姓 大药房连锁股份有限公司章程》（以下简称"《公司章程》"）的有关规定出具 本法律意见书。 为出具本法律意见书，本所声明如下： （一）本所出具本法律意见书是基于公司已承诺所有提供给本所的文件的正 本以及经本所查验与正本保持一致的副本均为真实、完整、可靠，无隐瞒、虚假 或重大遗漏之处。 （二）本所遵循了勤勉尽责和诚实信用原则，严格履行了法定职责，对本法 律意见书出具日以前已经发生 ...

Core Viewpoint - The Chinese government is implementing policies to enhance the adaptability of consumer goods supply and demand, aiming to promote consumption by aligning production with consumer preferences [1] Group 1 - The government encourages enterprises to understand and produce what consumers want, ensuring that products meet market demand and quality standards [1] - The initiative aims to provide consumers with satisfactory products and services, which in turn benefits businesses by ensuring their products are well-suited for the market [1]

Core Viewpoint - The Chinese government is implementing policies to enhance the adaptability of supply and demand in consumer goods, aiming to better align production with consumer preferences and improve service quality [2]. Group 1: Policy Measures - The government encourages enterprises to understand and produce what consumers want, ensuring that products are suitable and of high quality [2]. - The focus is on guiding companies to innovate and meet the demands of consumers, which will ultimately benefit both consumers and businesses [2].

Core Viewpoint - The demand for respiratory disease-related medications and protective supplies has significantly increased as respiratory diseases like influenza and mycoplasma pneumonia enter a high incidence season in China [2][3]. Group 1: Market Demand and Supply - The China Disease Prevention and Control Center has reported an upward trend in influenza cases, with sentinel hospitals in southern provinces reporting a percentage of influenza-like cases at 6.7% and northern provinces at 7.0% during the 46th week of 2025, indicating an earlier onset of the flu season compared to previous years [2]. - The company, Lao Bai Xi Da Yao Fang, has leveraged its nationwide supply chain and store network to ensure stable supply and price stability for four categories of medications, including antiviral drugs, antipyretics, cough suppressants, and antibiotics, as well as protective supplies like masks [2][3]. Group 2: Sales Performance - Sales of antiviral medications such as Oseltamivir and Mabalaoshuai (Sufuda), as well as antibiotics like Amoxicillin and Azithromycin, have seen significant growth recently, particularly in November, with a notable increase in sales of flu medications [3]. - The company has implemented a supply guarantee plan in anticipation of seasonal demand fluctuations, which includes early forecasting, centralized procurement, and increased stock levels to ensure market supply stability [3]. Group 3: Health Recommendations - The China Disease Prevention and Control Center has noted an increase in reported influenza outbreaks, particularly among children aged 5 to 14, and has recommended health monitoring in key institutions such as schools and nursing homes [4]. - The company emphasizes the importance of following medical advice for flu prevention and treatment, including vaccination, medication adherence, mask-wearing, hand hygiene, and environmental disinfection [4].

Core Viewpoint - The Chinese government is implementing policies to enhance the adaptability of consumer goods supply and demand, aiming to stimulate consumption and promote economic circulation [1][3]. Group 1: Policy Goals - The "Implementation Plan" sets two main development goals: to establish three trillion-level consumption sectors and ten hundred-billion-level consumption hotspots by 2027, and to create a high-quality development pattern of positive interaction between supply and consumption by 2030 [3][4]. - The plan emphasizes the importance of aligning supply with consumer demand to maximize consumption potential and facilitate economic growth [3]. Group 2: Key Measures - The plan outlines five key measures to address supply-demand mismatches: 1. Expand new increments by accelerating the application of new technologies and innovative models, promoting flexible production and user participation in design [3][4]. 2. Deepen existing stock by enhancing the supply of specialized and new products, focusing on areas like green, health, and rural consumption [4]. 3. Segment the market to precisely match the needs of different demographic groups, including initiatives for children's and elderly products [4][5]. 4. Empower new consumption scenarios and business formats by fostering platforms for product launches and developing new retail formats [5].

Core Viewpoint - The article highlights the rising demand for flu vaccines, antiviral medications, and related testing services due to the increasing flu activity across various regions in China as winter approaches [2][6][8]. Group 1: Flu Vaccine and Antiviral Demand - The flu season is expected to drive significant growth in demand for flu vaccines, respiratory testing, and antiviral medications [2][6]. - Recent data indicates a notable increase in flu vaccine appointments and antiviral drug purchases, with some areas reporting over 500% growth in the number of buyers for antiviral medications [7][8]. - Specific antiviral drugs like Marbofloxacin have seen a remarkable increase in demand, with purchases rising over 600% in recent weeks [7]. Group 2: Market Opportunities - Analysts suggest that the current flu outbreak may lead to heightened public and market interest, creating investment opportunities in flu vaccines, virus testing, and cold medications [8]. - The demand for flu-related products is expected to surge, particularly for antiviral medications such as Oseltamivir and Marbofloxacin, as well as traditional Chinese medicine for flu treatment [8]. - The increase in flu cases is likely to boost the need for diagnostic testing, both in hospitals and for home monitoring, indicating a potential market expansion for testing products [8].

证券代码：603883 证券简称：老百姓 公告编号：2025-065 老百姓大药房连锁股份有限公司 关于召开 2025 年第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和 完整性承担法律责任。 重要内容提示： 会议召开时间：2025 年 12 月 2 日(星期二)上午 10:00-11:30 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心视频直播和网络互动 投资者可于 2025 年 11 月 25 日(星期二)至 12 月 1 日(星期一)16:00 前登录上 证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 ir@lbxdrugs.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行回答。 老百姓大药房连锁股份有限公司（以下简称"公司"）已于 2025 年 10 月 29 日披露公司 2025 年第三季度报告，为便于广大投资者更全面深入地了解公司 2025 年第三季度经营成 ...